We take your personal privacy very seriously and when you visit our website, please agree to all cookies used. Further information on the processing of personal data can be found in the Privacy Statement
a_ban1.png a_ban1_ph.png

Unleashing the power of half-life to bring a full-life to patients across the world.

a1_img_01.png a_img_01_ph2.png
ABOUT US

From Half-Life to Full-Life.

Full-Life Technologies Limited (“Full-Life”) is a fully integrated global radiotherapeutics company with operations in Europe, the United States, and China.

Read More
  • a_imgc1.png

    Global management team with decades of experience spanning the discovery, development, production, and logistics of radiopharmaceuticals.

    Read More
    About our team
  • a_imgc2.png

    We attach the radionuclide to the targeting vector (peptide, small molecule, and single domain antibody) which delivers the payload directly to the tumor.

    Read More
    About our pipeline
  • a_imgc3.png

    Our radiotechnology platform takes a wholistic approach covering production and logistics of radiopharmaceutical drug products.

    Read More
    About our technology
a_img05.png
PRESS RELEASES
May 04, 2023

Full-Life Technologies Announces Land Purchase in Belgium to Establish GMP Manufacturing Facility for Radiopharmaceutical Drug Production

Read More